Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 20.95
- Piotroski Score 3.00
- Grade Buy
- Symbol (PRCT)
- Company PROCEPT BioRobotics Corporation
- Price $90.97
- Changes Percentage (2.28%)
- Change $2.03
- Day Low $87.57
- Day High $92.39
- Year High $103.81
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/25/2025
- Fiscal Year End N/A
- Average Stock Price Target $75.00
- High Stock Price Target $105.00
- Low Stock Price Target $49.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.12
- Trailing P/E Ratio -31.87
- Forward P/E Ratio -31.87
- P/E Growth -31.87
- Net Income $-105,897,000
Income Statement
Quarterly
Annual
Latest News of PRCT
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
PROCEPT BioRobotics Corp (PRCT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...
Sales rep training impacted Q3 utilization, but September showed strong performance. Q4 expects modest volume impact from ongoing training. ASC pilot program progressing well, expanding in 2025 to boo...
By Yahoo! Finance | 2 weeks ago -
PROCEPT BioRobotics Corporation (PRCT) Advances Urology with AI-Integrated HYDROS Robotic System; Price Target Raised to $99
PROCEPT BioRobotics Corporation is a surgical robotics company with an AI-integrated system for urology. Despite its potential, other AI stocks may offer higher returns in a shorter timeframe. Check o...
By Yahoo! Finance | 1 month ago -
Procept Biorobotics Corporation (PRCT): Why Are Short Sellers Betting Against This Hospital Tech Innovator?
PROCEPT BioRobotics Corp. (NASDAQ: PRCT) was analyzed against other worst small cap AI stocks. The recent interest rate cut by the Fed aimed at stabilizing the labor market....
By Yahoo! Finance | 1 month ago
